Overview Shionogi Inc. is a U.S. subsidiary of Shionogi & Co., Ltd., a global pharmaceutical company with a long history of bringing innovative medicines to patients. Building on its leadership in infectious disease, Shionogi Inc. isestablishinga best-in-class rare disease franchise. The company's growing rare disease team is helping shape the future ofRADICAVA (edaravone) for the amyotrophic lateral sclerosis (ALS) community. In the United States, RADICAVA has an established legacy, with the injectable formulation launched in 2017 and the oral suspension introduced in 2022.Building on thatstrong foundation,Shionogi is focused on advancing RADICAVA with a commitment to scientific excellence, patientimpactand long-term innovation in raredisease. The Neurology Account Specialist (NAS) will be responsible for meeting and/or exceeding sales goals in an assigned territory by developing, implementing, and executing an integrated territory business plan encompassing key customer targe...